| Application no. and date | 15798061.6 (espacenet) (Federated) (European Patent Register), 20151119 | | Patent/reg. no. and date | DK/EP 3220989, 20200624 | | Publication date | 20170927 | | Priority no. and date | US 201462081742 P, 20141119 | | EP pub. no. and date |
EP 3220989 20170927 | | Effective date | | | Applicant/owner | Optinose AS, Postboks 288 Roa
0702 Oslo, NO | | Applicant ref. no. | P73835DK01 | | Inventor | SHELDRAKE, Colin David, c/o OptiNose UK Ltd.
Berkeley House
Hunts Rise
South Marston Park Wiltshire SN3 4TG, GB,
DJUPESLAND, Per Gisle, c/o OptiNose AS
Postboks 288 Røa
N-0702 Oslo, NO | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61M 15/00 (2006.01) , A61M 15/08 (2006.01) | | Title | INTRANASAL ADMINISTRATION | | Int. application no. | EP2015077166 | | Int. publication no. | WO2016079271 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
